Ovarian Cancer — A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
Citation(s)
A Randomized, Intra-patient Crossover, Safety, Biomarker and Anti-Tumor Activity Assessment of the Combination of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)